Evidence map›Paper›PMID 42440536›Full record

ArticleFrontiers in microbiology2026

Phenotypic, PCR, and whole-genome sequencing characterization of carbapenem-resistant

Azzam A Alquait, Basel M Alnafjan, Mohammed H Abutarboush, Shouq F Algannam, Mohammed A Alolayan, Abdulaziz A Huraysi, Amjad N Alotaibi, Abeer H Alomair, Abdulmalek T Algarni, Basem J Almutiri and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Azzam A AlquaitHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Basel M AlnafjanHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Mohammed H AbutarboushHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Shouq F AlgannamHealth Sector, King Abdulaziz City for Science and Technology, Applied Genomics Technologies Institute, Riyadh, Saudi Arabia.
Mohammed A AlolayanHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Abdulaziz A HuraysiHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Amjad N AlotaibiHealth Sector, King Abdulaziz City for Science and Technology, Advanced Diagnostics and Therapeutics Institute, Riyadh, Saudi Arabia.
Abeer H AlomairHealth Sector, King Abdulaziz City for Science and Technology, Advanced Diagnostics and Therapeutics Institute, Riyadh, Saudi Arabia.
Abdulmalek T AlgarniHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Basem J AlmutiriHealth Sector, King Abdulaziz City for Science and Technology, Applied Genomics Technologies Institute, Riyadh, Saudi Arabia.
Fatima F AlghannamDepartment of Infection and Immunity, Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Hatim AlmutairiDepartment of Genome and Data, National Livestock and Fisheries Development Program, Ministry of Environment, Water and Agriculture, Riyadh, Saudi Arabia.
Sarah S AlotaibiHealth Sector, King Abdulaziz City for Science and Technology, Applied Genomics Technologies Institute, Riyadh, Saudi Arabia.
Amal M AlsubhiHealth Sector, King Abdulaziz City for Science and Technology, Bioengineering Institute, Riyadh, Saudi Arabia.
Fahhad D AlsahliHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Maryam K AlshammariCollege of Applied Medical Sciences, Inaya Medical College, Riyadh, Saudi Arabia.
Seham S AlharthiHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Fahad M AlhoshaniHealth Sector, King Abdulaziz City for Science and Technology, Advanced Diagnostics and Therapeutics Institute, Riyadh, Saudi Arabia.
Fayez S BahwerthMicrobiology Department, Hera General Hospital, Ministry of Health, Makkah, Saudi Arabia.
Turki M DawoudDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Bandar K SendyHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Essam A TawfikHealth Sector, King Abdulaziz City for Science and Technology, Advanced Diagnostics and Therapeutics Institute, Riyadh, Saudi Arabia.
Ahmed A Al-QahtaniDepartment of Infection and Immunity, Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Musaad A AltammamiHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Ahmad M AldossaryHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.
Essam J AlyamaniHealth Sector, King Abdulaziz City for Science and Technology, Wellness and Preventive Medicine Institute, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenem-resistant Methods: We analyzed 71 non-duplicate multidrug-resistant (MDR) Results: By BMD, carbapenem resistance was essentially universal (imipenem [IMI] 100% in both cities; meropenem [MEM] 100% in Makkah and 97.2% in Riyadh). VITEK II software showed high categorical agreement with BMD (94-100% across drug city strata) but non-zero very major error (VME) rates for carbapenems (up to 5.9%), supporting reflex BMD confirmation for decision-changing susceptible calls. The composite PCR marker ( Conclusion: A combined same-day PCR rule-in, reference MIC confirmation, and WGS micro-cluster surveillance strategy operationalizes rapid CRAB triage and outbreak triggering in hospitals in Saudi Arabia, enabling proactive infection-prevention containment.

Indexed as

Acinetobacter baumanniicarbapenem resistanceinfection prevention and controloutbreak micro-clusterswhole-genome sequencing

Identifiers

PMID42440536
PMCPMC13333605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.